Serum Golgi Protein 73 in Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
doi 10.21474/ijar01/5954
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Journal Of Advanced Research

Related search

Quantitative Analysis of Elevated Serum Golgi Protein-73 Expression in Patients With Liver Diseases

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2009English

Development and Application of a Fluorescence Protein Microarray for Detecting Serum Alpha-Fetoprotein in Patients With Hepatocellular Carcinoma

Journal of International Medical Research
BiochemistryMedicineCell Biology
2016English

Heat Shock Protein 70 Serum Levels Differ Significantly in Patients With Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma

Frontiers in Immunology
AllergyImmunology
2014English

Studies on Serum Alkaline Phosphatase Activities and Isoenzymes in Patients With Hepatocellular Carcinoma.

Acta Hepatologica Japonica
Hepatology
1977English

Aberrant Expression of Golgi Protein 703 Is Indicative of a Poor Outcome in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Serum Secreted Frizzled‑related Protein 5 Levels Differentially Decrease in Patients With Hepatitis B Virus‑associated Chronic Infection and Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2014English

Tumour-Associated Isoenzymes of Γ-Glutamyl Transferase in the Serum of Patients With Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1984English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

High Serum Transforming Growth Factor- 1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated With Sorafenib

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy